-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Intraday Session
Share
Listen to the news

Gainers

  • Pasithea Therapeutics (NASDAQ:KTTA) shares moved upwards by 99.8% to $0.97 during Wednesday's regular session. The company's market cap stands at $3.6 million.
  • Zynex (NASDAQ:ZYXI) shares increased by 64.15% to $1.21. The company's market cap stands at $22.4 million.
  • Mobile-health Network (NASDAQ:MNDR) shares moved upwards by 33.15% to $2.53. The company's market cap stands at $4.5 million.
  • Quince Therapeutics (NASDAQ:QNCX) shares rose 26.96% to $3.39. The company's market cap stands at $148.6 million.
  • Quantum BioPharma (NASDAQ:QNTM) stock increased by 26.86% to $10.2. The company's market cap stands at $30.6 million.
  • Arrowhead Pharma (NASDAQ:ARWR) stock increased by 24.17% to $58.1. The market value of their outstanding shares is at $6.4 billion. The company's, Q4 earnings came out yesterday.

Losers

  • Moleculin Biotech (NASDAQ:MBRX) shares decreased by 24.8% to $0.27 during Wednesday's regular session. The market value of their outstanding shares is at $18.2 million.
  • Inspire Veterinary (NASDAQ:IVP) stock decreased by 17.23% to $0.14.
  • OSR Holdings (NASDAQ:OSRH) shares fell 16.11% to $0.69. The company's market cap stands at $20.9 million.
  • NanoVibronix (NASDAQ:NAOV) stock declined by 14.94% to $4.24. The market value of their outstanding shares is at $4.3 million.
  • Polyrizon (NASDAQ:PLRZ) stock decreased by 14.04% to $0.5. The company's market cap stands at $3.4 million.
  • Bruker (NASDAQ:BRKRP) stock decreased by 13.94% to $325.86. The market value of their outstanding shares is at $908.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending